News & Events

NSCLC Biomarker Testing: Multidisciplinary Decisions and Timely Testing Are Key

NSCLC Biomarker Testing: Multidisciplinary Decisions and Timely Testing Are Key

Role of Pulmonologists in Precision Medicine: Attitudes Towards Biomarker Testing for NSCLC

Role of Pulmonologists in Precision Medicine: Attitudes Towards Biomarker Testing for NSCLC

Targeting KRAS Mutations in Cancer Therapy

Targeting KRAS Mutations in Cancer Therapy

How KRAS Inhibitors Are Transforming Cancer Therapy

How KRAS Inhibitors Are Transforming Cancer Therapy

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research

Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy

Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy

Roche's divarasib to take on approved KRAS inhibitors in Phase III study

Roche's divarasib to take on approved KRAS inhibitors in Phase III study

KRYSTAL-12 boosts adagrasib as 2L Tx alternative for KRASG12C-mutated NSCLC

KRYSTAL-12 boosts adagrasib as 2L Tx alternative for KRASG12C-mutated NSCLC

Lung Cancer Expert at ASCO: From Fatal to 'Chronic Disease'

Lung Cancer Expert at ASCO: From Fatal to 'Chronic Disease'